Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129211402> ?p ?o ?g. }
- W2129211402 endingPage "1222" @default.
- W2129211402 startingPage "1215" @default.
- W2129211402 abstract "To examine the risk of gastrointestinal adverse effects associated with dabigatran use compared with warfarin among patients with atrial fibrillation (AF).Patients with AF and no history of gastrointestinal diseases initiating dabigatran or warfarin were identified from Danish nationwide registries from 22 August 2011 until 31 December 2012. Patients were classified as naive or experienced users, according to prior use of oral anticoagulant (OAC) therapy. The risk of subsequent proton pump inhibitor (PPI) use, upper dyspepsia-like diagnoses (gastroesophageal reflux, gastritis, gastric, and duodenal ulcer) and gastrointestinal bleeding requiring hospitalization, gastroscopy, and discontinuation of dabigatran and warfarin was examined by cumulative incidence rates and multivariable adjusted Cox regression models. We identified five groups: OAC-naive warfarin (n = 4534); OAC-naive dabigatran 110 mg b.i.d. (dabigatran 110) (n = 1168); OAC-naive dabigatran 150 mg b.i.d. (dabigatran 150) (n = 1844); OAC-experienced dabigatran 110 (n = 1143); and OAC-experienced dabigatran 150 (n = 1748). Compared with OAC-naive warfarin, the rate of initiating PPIs was significantly increased for OAC-naive dabigatran 110 [hazard ratio (HR), 1.24; 95% confidence interval (CI), 1.02-1.50]. Other dabigatran regimes were not associated with a higher risk of initiating PPIs, upper dyspepsia-like diagnoses, gastrointestinal bleeding, or gastroscopy. The risk of discontinuation was increased for OAC-experienced dabigatran 150 (HR, 1.13; 95% CI, 1.02-1.25), but not for the other dabigatran-treated groups, relative to OAC-naive warfarin.Dabigatran was not associated with upper dyspepsia-like diagnoses or gastrointestinal bleeding requiring hospitalization, and gastroscopy. The risk of subsequent PPI use was increased for OAC-naive dabigatran 110 mg users, and the risk of discontinuation was increased for OAC-experienced dabigatran 150 mg users." @default.
- W2129211402 created "2016-06-24" @default.
- W2129211402 creator A5004642904 @default.
- W2129211402 creator A5018763521 @default.
- W2129211402 creator A5028361516 @default.
- W2129211402 creator A5038237898 @default.
- W2129211402 creator A5038405190 @default.
- W2129211402 creator A5039442834 @default.
- W2129211402 creator A5039739369 @default.
- W2129211402 creator A5041526130 @default.
- W2129211402 creator A5081057548 @default.
- W2129211402 date "2015-05-19" @default.
- W2129211402 modified "2023-09-25" @default.
- W2129211402 title "Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study" @default.
- W2129211402 cites W1980300036 @default.
- W2129211402 cites W1994905407 @default.
- W2129211402 cites W1997854923 @default.
- W2129211402 cites W2027154314 @default.
- W2129211402 cites W2042608661 @default.
- W2129211402 cites W2048199378 @default.
- W2129211402 cites W2067415003 @default.
- W2129211402 cites W2067443499 @default.
- W2129211402 cites W2086418097 @default.
- W2129211402 cites W2087912692 @default.
- W2129211402 cites W2094757280 @default.
- W2129211402 cites W2096215047 @default.
- W2129211402 cites W2096219546 @default.
- W2129211402 cites W2102420102 @default.
- W2129211402 cites W2102924526 @default.
- W2129211402 cites W2108659563 @default.
- W2129211402 cites W2110934340 @default.
- W2129211402 cites W2118092611 @default.
- W2129211402 cites W2121403509 @default.
- W2129211402 cites W2136489990 @default.
- W2129211402 cites W2137878797 @default.
- W2129211402 cites W2142749836 @default.
- W2129211402 cites W2152623033 @default.
- W2129211402 doi "https://doi.org/10.1093/europace/euv119" @default.
- W2129211402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25995392" @default.
- W2129211402 hasPublicationYear "2015" @default.
- W2129211402 type Work @default.
- W2129211402 sameAs 2129211402 @default.
- W2129211402 citedByCount "25" @default.
- W2129211402 countsByYear W21292114022015 @default.
- W2129211402 countsByYear W21292114022016 @default.
- W2129211402 countsByYear W21292114022017 @default.
- W2129211402 countsByYear W21292114022018 @default.
- W2129211402 countsByYear W21292114022019 @default.
- W2129211402 countsByYear W21292114022020 @default.
- W2129211402 countsByYear W21292114022021 @default.
- W2129211402 countsByYear W21292114022023 @default.
- W2129211402 crossrefType "journal-article" @default.
- W2129211402 hasAuthorship W2129211402A5004642904 @default.
- W2129211402 hasAuthorship W2129211402A5018763521 @default.
- W2129211402 hasAuthorship W2129211402A5028361516 @default.
- W2129211402 hasAuthorship W2129211402A5038237898 @default.
- W2129211402 hasAuthorship W2129211402A5038405190 @default.
- W2129211402 hasAuthorship W2129211402A5039442834 @default.
- W2129211402 hasAuthorship W2129211402A5039739369 @default.
- W2129211402 hasAuthorship W2129211402A5041526130 @default.
- W2129211402 hasAuthorship W2129211402A5081057548 @default.
- W2129211402 hasBestOaLocation W21292114021 @default.
- W2129211402 hasConcept C120665830 @default.
- W2129211402 hasConcept C121332964 @default.
- W2129211402 hasConcept C126322002 @default.
- W2129211402 hasConcept C207103383 @default.
- W2129211402 hasConcept C2776301958 @default.
- W2129211402 hasConcept C2776345487 @default.
- W2129211402 hasConcept C2778080469 @default.
- W2129211402 hasConcept C2778451229 @default.
- W2129211402 hasConcept C2778715236 @default.
- W2129211402 hasConcept C2778810321 @default.
- W2129211402 hasConcept C2779161974 @default.
- W2129211402 hasConcept C44249647 @default.
- W2129211402 hasConcept C61511704 @default.
- W2129211402 hasConcept C71924100 @default.
- W2129211402 hasConcept C90924648 @default.
- W2129211402 hasConceptScore W2129211402C120665830 @default.
- W2129211402 hasConceptScore W2129211402C121332964 @default.
- W2129211402 hasConceptScore W2129211402C126322002 @default.
- W2129211402 hasConceptScore W2129211402C207103383 @default.
- W2129211402 hasConceptScore W2129211402C2776301958 @default.
- W2129211402 hasConceptScore W2129211402C2776345487 @default.
- W2129211402 hasConceptScore W2129211402C2778080469 @default.
- W2129211402 hasConceptScore W2129211402C2778451229 @default.
- W2129211402 hasConceptScore W2129211402C2778715236 @default.
- W2129211402 hasConceptScore W2129211402C2778810321 @default.
- W2129211402 hasConceptScore W2129211402C2779161974 @default.
- W2129211402 hasConceptScore W2129211402C44249647 @default.
- W2129211402 hasConceptScore W2129211402C61511704 @default.
- W2129211402 hasConceptScore W2129211402C71924100 @default.
- W2129211402 hasConceptScore W2129211402C90924648 @default.
- W2129211402 hasIssue "8" @default.
- W2129211402 hasLocation W21292114021 @default.
- W2129211402 hasLocation W21292114022 @default.
- W2129211402 hasOpenAccess W2129211402 @default.
- W2129211402 hasPrimaryLocation W21292114021 @default.
- W2129211402 hasRelatedWork W1520411956 @default.